← Back to Research Radar
Academic Publication Academic Publication

Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN

378
Citations
December 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
69%
🔥

Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN

No description provided.

crossref.org › academic paper
52%
🔥

The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief over...

crossref.org › academic paper
0%

Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study

No description provided.

crossref.org › academic paper
0%

Global burden of cardiovascular diseases: projections from 2025 to 2050

Abstract Aims The prediction of future trends in cardiovascular disease (CVD) mortality and their risk factors can assist policy-makers in health...

crossref.org › academic paper
0%

Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021

No description provided.

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN'?

This literature focuses on:

Are there open-source GitHub repositories related to Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN?

Yes, open-source projects like BigBodyCobain/Shadowbroker (Open-source intelligence for the global theater. Track everything from the corporate/private jets of the wealthy, and spy satellites, to seismic ev...) are actively building upon these concepts.

Which startups are commercializing the technology behind Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN?

Products like Straude are bringing this to market. Their focus is: Strava for Claude Code, the global tokenmaxxing Leaderboard.

What other academic literature is closely related to 'Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN'?

Yes, highly correlated activity was mapped. An entry titled 'Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

  • GitHub
    BigBodyCobain/Shadowbroker
    Open-source intelligence for the global theater. Track everything f...
  • GitHub
    simplifaisoul/osiris
    Open Source Global Intelligence Platform - Real-Time OSINT Dashboar...
  • Product Hunt
    Straude
    Strava for Claude Code, the global tokenmaxxing Leaderboard
  • Product Hunt
    Cleo Labs
    Automate global compliance for selling physical products

Enterprise Ecosystem Mentions

Associated Media Narrative